VMD Launches New Enforcement Report Series With October and November Findings

The Veterinary Medicines Directorate has released its first-ever Inspections and Enforcement Report, marking the start of a new bi-monthly series aimed at improving transparency and boosting compliance across the animal health sector.

Covering activity from October to November 2025, the report outlines inspection outcomes, enforcement action and emerging risks affecting vets, retailers and animal owners.

Officials say the initiative is designed to keep stakeholders informed about regulatory breaches and the steps being taken to address them.

Nearly 200 Inspections in Two Months

During the two-month reporting period, the VMD carried out 188 inspections and opened 200 new enforcement cases. At the same time, 321 cases were concluded.

Enforcement measures included issuing five formal notices, sending 219 advisory or warning letters and removing 77 illegal product listings from sale.

The regulator says the figures reflect both proactive inspection work and intelligence-led investigations.

Prescription Fraud Remains a Major Concern

One of the most persistent issues highlighted in the report is prescription fraud.

Between January 2023 and June 2025, the VMD recorded 1,852 reports involving falsified veterinary prescriptions. Of those, 84% related to altered prescriptions, while 16% involved entirely fabricated documents.

Dermatitis treatments, anti-inflammatory drugs, heart medications and parasiticides were among the most frequently targeted products.

The VMD stressed that altering a prescription without the issuing vet’s consent is illegal and can put animal welfare at risk.

Counterfeit Flea Treatments on the Rise

Reports of suspected fake flea and tick treatments have surged dramatically.

After a joint warning issued in June 2025 with the Intellectual Property Office, the regulator saw a seven-fold increase in complaints. Historically, only six reports had been received. Since June, that figure has climbed to 49, including 11 cases during October and November alone.

The VMD has contacted online sellers, including those operating on platforms such as eBay, and reminded pet owners to buy medicines only from reputable sources.

Consumers are being advised to look out for warning signs including poor-quality packaging, spelling mistakes, unusual odours and prices that seem too good to be true.

Vet Practices Warned Over Broach Limit Failures

Inspection findings also revealed compliance gaps inside veterinary practices.

According to the report, 18% of practices inspected were using medicines beyond their permitted “broach limit” — the timeframe within which an opened medicine must be used.

Additionally, 21% failed to properly record all required prescribing or supply information.

The regulator reminded practices to clearly label medicines with opening dates and to check usage limits before administering treatments.

Crackdown on Illegal Online Sales

The VMD continues to pursue individuals and businesses selling prescription-only medicines without authorisation.

In 2024, 55 reports were made about illegal online sales. In 2025, that figure has already reached 52, involving listings across social media platforms and online marketplaces.

The regulator has removed unauthorised listings from platforms such as Facebook Marketplace and Vinted, where partially used medicines were being offered for sale.

Officials emphasised that reselling leftover prescription medicines is illegal and that unused products must be disposed of safely.

An intelligence-led enforcement project is now being rolled out to target repeat offenders and disrupt online supply chains.

Impact and Consequences

The publication of the new report series signals a stronger emphasis on regulatory oversight within the veterinary medicines sector.

For vet practices and retailers, increased inspections and enforcement action may lead to tighter compliance standards and greater scrutiny of record-keeping, storage and prescribing processes.

For pet owners and animal keepers, the crackdown on counterfeit and illegally sold medicines aims to reduce risks to animal health, public safety and the environment.

Failure to comply with regulations can result in enforcement notices, product removals and potentially more serious legal consequences.

What’s Next?

The VMD confirmed that the next report will cover December 2025 and January 2026, continuing the two-month reporting cycle.

Officials are encouraging vets, businesses and the public to report suspected breaches through the regulator’s online reporting tool. Feedback on the new report series can also be submitted directly to the agency.

With enforcement activity set to continue, the regulator says transparency and collaboration will be central to maintaining trust in the veterinary medicines system.

Summary

The Veterinary Medicines Directorate has published its first Inspections and Enforcement Report, detailing regulatory activity from October to November 2025.

The report highlights inspection outcomes, enforcement statistics and rising concerns over prescription fraud, counterfeit flea treatments, broach limit breaches and illegal online sales.

The new bi-monthly reporting series aims to promote compliance and strengthen oversight across the animal health sector.

Bulleted Takeaways

• The VMD conducted 188 inspections between October and November 2025.
• 200 new enforcement cases were opened and 321 cases were closed.
• Five enforcement notices and 219 letters were issued.
• 77 illegal online listings were removed.
• Prescription fraud remains widespread, with 1,852 reports recorded since 2023.
• Reports of counterfeit flea treatments have increased seven-fold since June 2025.
• 18% of inspected vet practices breached medicine broach limits.
• The next enforcement report will cover December 2025 and January 2026.